Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherLiab,treasuryStock,otherAssets,cash,totalCurrentLiabilities,otherStockholderEquity,totalCurrentAssets,longTermInvestments,shortTermInvestments,netReceivables,investments,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,otherCashflowsFromInvestingActivities,changeToAccountReceivables,otherCashflowsFromFinancingActivities,changeToNetincome,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,currency,exchange,marketCap,gmtOffSetMilliseconds,esgPopulated,tradeable,marketState,priceHint,regularMarketChangePercent,regularMarketDayRange,market,exchangeDataDelayedBy,shortName,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,dividendDate,epsTrailingTwelveMonths,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Jan 30, 2019) 4","Short Ratio (Jan 30, 2019) 4","Short % of Float (Jan 30, 2019) 4","Short % of Shares Outstanding (Jan 30, 2019) 4","Shares Short (prior month Dec 30, 2018) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,country,maxAge,address1,fax,industry
t0,EMITF,94447000,9190810,,,-2849500,,-2001500,1415000,-20500,-2425500,-2425500,990000,,,,,23500,-20500,2405000,0,-424000,80085000,-2873000,-2001500,7560000,94447000,6272000,102007000,1106290000,-823238000,425000,-188605000,31477000,1857000,7135000,-188605000,4363000,66167000,100000,2358000,115598000,3288000,1967500,-2038000,-2115000,632500,-866500,19500,-738500,-113630500,680000,-77000,-3337500,-2772000,en-US,US,EQUITY,False,Delayed Quote,2.1,1630334798,0.0,2.12,2.1,2.1,300,USD,PNK,18635400,-14400000,False,False,REGULAR,4,0.0,2.1 - 2.1,us_market,0,ELBIT IMAGING LTD,2.1,0.0,0.0,12,9,finmb_517056,Other OTC,Elbit Imaging Ltd.,ILS,35092,2016,1.27,1.5301205,0.83 - 2.72,-0.6200001,-0.22794122,0.83,2.72,1618790400,-8.324,-6.915,2.198611,-0.09861112,-0.044851553,2.1010144,-0.001014471,-0.00048284823,-0.30368763,15,America/New_York,EDT,0.88,,,2.72,0.83,2.1986,2.101,35.09k,2.02k,9.19M,,6.27M,37.25%,6.85%,3.85k,0.48,0.06%,0.04%,4.68k,0.08,3.77%,,,,0.00%,"Apr 18, 2021","Apr 04, 2021",1:3,"Jun 26, 2016","Dec 30, 2020","Dec 30, 2020",0.00%,0.00%,-4.99%,,,,,,,,-8.324,,,,,,0.61,-6.91,,,Value,4900102,Healthcare,4,"Elbit Imaging Ltd., together with its subsidiaries, engages in the development, production, and marketing of therapeutic medical systems for performing non-invasive treatments on the human body in the North and South America, Europe, Asia, and Oceania. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. In addition, the company is involved in the sale of plots and villas in India. The company was incorporated in 1996 and is headquartered in Petach Tikva, Israel.",Petah Tikva,972 3 608 6000,Israel,86400,3 Shimson Street,972 3 608 6050,Medical Devices
t-1,EMITF,94447000,9190810,,,-2849500,,-2001500,1415000,-20500,-2425500,-2425500,990000,,,,,23500,-20500,2405000,0,-424000,80085000,-2873000,-2001500,7560000,94447000,6272000,102007000,1106290000,-823238000,425000,-188605000,31477000,1857000,7135000,-188605000,4363000,66167000,100000,2358000,115598000,3288000,1967500,-2038000,-2115000,632500,-866500,19500,-738500,-113630500,680000,-77000,-3337500,-2772000,en-US,US,EQUITY,False,Delayed Quote,2.1,1630334798,0.0,2.12,2.1,2.1,300,USD,PNK,18635400,-14400000,False,False,REGULAR,4,0.0,2.1 - 2.1,us_market,0,ELBIT IMAGING LTD,2.1,0.0,0.0,12,9,finmb_517056,Other OTC,Elbit Imaging Ltd.,ILS,35092,2016,1.27,1.5301205,0.83 - 2.72,-0.6200001,-0.22794122,0.83,2.72,1618790400,-8.324,-6.915,2.198611,-0.09861112,-0.044851553,2.1010144,-0.001014471,-0.00048284823,-0.30368763,15,America/New_York,EDT,0.88,,,2.72,0.83,2.1986,2.101,35.09k,2.02k,9.19M,,6.27M,37.25%,6.85%,3.85k,0.48,0.06%,0.04%,4.68k,0.08,3.77%,,,,0.00%,"Apr 18, 2021","Apr 04, 2021",1:3,"Jun 26, 2016","Dec 30, 2020","Dec 30, 2020",0.00%,0.00%,-4.99%,,,,,,,,-8.324,,,,,,0.61,-6.91,,,Value,4900102,Healthcare,4,"Elbit Imaging Ltd., together with its subsidiaries, engages in the development, production, and marketing of therapeutic medical systems for performing non-invasive treatments on the human body in the North and South America, Europe, Asia, and Oceania. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. In addition, the company is involved in the sale of plots and villas in India. The company was incorporated in 1996 and is headquartered in Petach Tikva, Israel.",Petah Tikva,972 3 608 6000,Israel,86400,3 Shimson Street,972 3 608 6050,Medical Devices
t-2,EMITF,102046000,9190810,,,-563500,,116927000,2626000,20500,-2605500,-2605500,990000,-1931500.0,,,,1000,20500,2626000,0,2042000,117491500,-564500,116927000,10171000,102046000,5633000,112217000,1106290000,-819235000,462000,-185009000,30926000,3590000,9709000,-185009000,8241000,73050000,100000,4551000,64327500,-3288000,61512000,-43961000,-69493500,632500,-4443500,10624000,-7086000,2266500,-680000,-25532500,-120045000,-1468000,en-US,US,EQUITY,False,Delayed Quote,2.1,1630334798,0.0,2.12,2.1,2.1,300,USD,PNK,18635400,-14400000,False,False,REGULAR,4,0.0,2.1 - 2.1,us_market,0,ELBIT IMAGING LTD,2.1,0.0,0.0,12,9,finmb_517056,Other OTC,Elbit Imaging Ltd.,ILS,35092,2016,1.27,1.5301205,0.83 - 2.72,-0.6200001,-0.22794122,0.83,2.72,1618790400,-8.324,-6.915,2.198611,-0.09861112,-0.044851553,2.1010144,-0.001014471,-0.00048284823,-0.30368763,15,America/New_York,EDT,0.88,,,2.72,0.83,2.1986,2.101,35.09k,2.02k,9.19M,,6.27M,37.25%,6.85%,3.85k,0.48,0.06%,0.04%,4.68k,0.08,3.77%,,,,0.00%,"Apr 18, 2021","Apr 04, 2021",1:3,"Jun 26, 2016","Dec 30, 2020","Dec 30, 2020",0.00%,0.00%,-4.99%,,,,,,,,-8.324,,,,,,0.61,-6.91,,,Value,4900102,Healthcare,4,"Elbit Imaging Ltd., together with its subsidiaries, engages in the development, production, and marketing of therapeutic medical systems for performing non-invasive treatments on the human body in the North and South America, Europe, Asia, and Oceania. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. In addition, the company is involved in the sale of plots and villas in India. The company was incorporated in 1996 and is headquartered in Petach Tikva, Israel.",Petah Tikva,972 3 608 6000,Israel,86400,3 Shimson Street,972 3 608 6050,Medical Devices
t-3,EMITF,102046000,9190810,,,-563500,,116927000,2626000,20500,-2605500,-2605500,990000,-1931500.0,,,,1000,20500,2626000,0,2042000,117491500,-564500,116927000,10171000,102046000,5633000,112217000,1106290000,-819235000,462000,-185009000,30926000,3590000,9709000,-185009000,8241000,73050000,100000,4551000,64327500,-3288000,61512000,-43961000,-69493500,632500,-4443500,10624000,-7086000,2266500,-680000,-25532500,-120045000,-1468000,en-US,US,EQUITY,False,Delayed Quote,2.1,1630334798,0.0,2.12,2.1,2.1,300,USD,PNK,18635400,-14400000,False,False,REGULAR,4,0.0,2.1 - 2.1,us_market,0,ELBIT IMAGING LTD,2.1,0.0,0.0,12,9,finmb_517056,Other OTC,Elbit Imaging Ltd.,ILS,35092,2016,1.27,1.5301205,0.83 - 2.72,-0.6200001,-0.22794122,0.83,2.72,1618790400,-8.324,-6.915,2.198611,-0.09861112,-0.044851553,2.1010144,-0.001014471,-0.00048284823,-0.30368763,15,America/New_York,EDT,0.88,,,2.72,0.83,2.1986,2.101,35.09k,2.02k,9.19M,,6.27M,37.25%,6.85%,3.85k,0.48,0.06%,0.04%,4.68k,0.08,3.77%,,,,0.00%,"Apr 18, 2021","Apr 04, 2021",1:3,"Jun 26, 2016","Dec 30, 2020","Dec 30, 2020",0.00%,0.00%,-4.99%,,,,,,,,-8.324,,,,,,0.61,-6.91,,,Value,4900102,Healthcare,4,"Elbit Imaging Ltd., together with its subsidiaries, engages in the development, production, and marketing of therapeutic medical systems for performing non-invasive treatments on the human body in the North and South America, Europe, Asia, and Oceania. The company offers treatment-oriented medical systems with ultrasound beam and magnetic resonance imaging for noninvasive treatments in human body. It also offers medical products based on stem cells derived primarily from umbilical cord blood and intended for bone marrow transplantation in patients with leukemia or lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. In addition, the company is involved in the sale of plots and villas in India. The company was incorporated in 1996 and is headquartered in Petach Tikva, Israel.",Petah Tikva,972 3 608 6000,Israel,86400,3 Shimson Street,972 3 608 6050,Medical Devices
